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Uncoupling protein 2 (UCP2) belongs to a family of transporters of the mitochondrial inner membrane and is reported to uncouple respiration
from ATP synthesis. Our observation that the amino acid glutamine specifically induces UCP2 protein expression prompted us to investigate
metabolic consequences of a UCP2 knockdown (Ucp2-KO) when glutamine is offered as a substrate. We found that Ucp2-KO macrophages
incubated in the presence of glutamine exhibit a lower ammonium release, a decreased respiratory rate, and an intracellular accumulation of
aspartate. Therefore, we conclude that UCP2 expression is required for efficient oxidation of glutamine in macrophages. This role of UCP2 in
glutamine metabolism appears independent from the uncoupling activity of UCP2.
© 2007 Elsevier B.V. All rights reserved.Keywords: UCP2; Macrophage; Uncoupling protein; Mitochondria; Glutamine; Glutaminolysis1. Introduction
Uncoupling protein 2 (UCP2) is located in the inner mem-
brane of the mitochondria. UCP2 was found to be expressed in
diverse tissues in mammals, as e.g. in pancreatic islets and in
many cells of the immune system including macrophages [1–3].
UCP2 belongs to the family of mitochondrial anion carriers and
shows high similarity to UCP1, the brown adipose tissue
uncoupling protein [4,5]. Mild uncoupling of mitochondria
(reviewed in [6]) was proposed as a means to prevent super-
oxide production by the respiratory complexes I and III [7].
Consequently, such a role has been proposed for UCP2 [8].
However, its exact role remains discussed [2,9]. UCP2 was
shown to play a regulatory role in macrophage mediated
immunity and/or inflammatory responsiveness of these cells
[3,5,10–12]. It was also characterized as a negative regulator ofAbbreviations: UCP, uncoupling protein; EBSS, Earle's balanced saline
solution; BMDM, bone marrow derived macrophages; FCS, foetal bovine
serum; MCSF, macrophage colony-stimulating factor; AOA, aminooxyacetic
acid; DON, 6-diazo 5-oxo norleucine
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doi:10.1016/j.bbabio.2007.11.002insulin secretion in pancreatic beta-cells [13]. Recently the
causes of the enhanced macrophage activity in Ucp2-KO mice
have been studied in further details [14].
Immune cells utilize glutamine besides glucose at very high
levels and the rate of glutamine utilization by these cells is
either similar to or even greater than that of glucose [15,16].
Incomplete oxidation of glucose or glutamine (glutaminolysis)
takes place in immune cells. Glucose is converted almost totally
into lactate and glutamine into ammonium, glutamate, aspartate
and lactate. Fig. 1 provides a schematic overview over the steps
of glutamine catabolism relevant here.
The UCP2mRNA contains a long 5′ untranslated region in
which a short upstream open reading frame (uORF) is present.
According to our work, this results in a constitutive inhibition of
translation of UCP2 mRNA [17,18]. More recently, we have
shown that the presence of glutamine in the surroundingmedium
relieves the constitutive inhibition of UCP2 translation by the
uORF [19]. Accordingly, we proposed that UCP2 may be
involved in the oxidative metabolism of glutamine [20]. Primary
cultures of bone marrow derived macrophages (BMDM)
allowed us to compare cells from “wild type” mice (Ucp2-WT)
with cells obtained from mice where the Ucp2 gene has been
invalidated by homologous recombination (Ucp2-KO) [14,21].
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2.1. Reagents
PBS, RPMI 1640 with glutamax, Earle's balanced saline solution (EBSS,
containing 5mMglucose) and glutaminewere purchased fromLife Technologies
SARL, Cergy Pontoise, France, and foetal calf serum (FCS) from PAA
Laboratories GmbH, Pasching, Austria. Anti-porin antibodywas fromMolecular
Probes Europe BV, Leiden, The Netherlands. Anti-hUCP2-605 and rabbit anti-
IgG were generated in our laboratory and used as previously described [17].
ECL-kit was obtained from Amersham Biosciences, Buckinghamshire, UK and
ENLITEN®Luciferase/Luciferin (rLuc/Luc) Reagent from Promega Corpora-
tion, Madison, USA. Other chemicals, mouse anti-IgG, myokinase and DNase
were obtained from Sigma-Aldrich St Quentin-Fallavier France.
2.2. Cell culture conditions
BMDM were isolated from Ucp2-KO mice in which the Ucp2 gene had
been invalidated by homologous recombination [10] and from their littermateFig. 1. Intramitochondrial metabolism of glutamine. The mitochondrial inner
membrane is schematized as a thick gray line. aKG: alpha-keto-glutarate, OAA
oxaloacetic acid. Steps of the metabolism of glutamine relevant here are num-
bered. 1: Loss of first ammonium group (glutaminase) inhibited by DON; 2: loss
of the second ammonium group (2a: glutamate dehydrogenase, 2b: transaminase
inhibited by AOA); 3: oxidative metabolism in the Krebs cycle. 4: “OXPHOS”
with respiratory chain coupling reoxidation of coenzymes to creation of a proton
gradient and the phosphorylating unit (FoF1ATPase, Phosphate and ATP/ADP
transporters) using this proton gradient to generate ATP by phosphorylation of
ADP. UCP2 is placed in two different positions: “A” UCP2 acts as a proton leak
(uncoupling effect) that dissipates the electrochemical gradient, favorises
reoxidation of coenzymes and decreases ATP/ADP ratio. In position “B”
UCP2 increases the availability of reduced coenzymes to the respiratory chain.
This study supports the “UCP2 B” hypothesis.control (Ucp2-WT) as previously described [14]. The experiments were made by
incubating BMDM in EBSS medium in the presence or absence of glutamine
(2 mM): RPMI media were exchanged against EBSS containing glutamine or
not and cells were further cultivated up to 16 h (overnight). Incubations in the
absence of glucose were made in PBS to which was added 1.3 mM Ca2+ and
50 μM Mg2+, this medium is referred to as “PBS” hereafter. It was checked by
the use of the WST assay (Roche Diagnostics, Mannheim, Germany) measuring
metabolic activity of mitochondria or by measuring the percentage of cells in
sub-G1 phase, that BMDM could withstand such treatments.
2.3. Western blot analysis
Whole cellular extract from macrophages were prepared as follows: after
washing in PBS the pellet of cells was resuspended in solubilisation buffer
(50mMTris pH 7.8, 150mMNaCl, 1%NP-40) with protease inhibitors (1 μg/ml
pepstatin, 4 μg/ml aprotinin, 2 μg/ml leupeptin, 5 μg/ml bestatin), after 30 min in
ice this was centrifuged at 10000 ×g for 20 min and the supernatant was used. To
prepare mitochondrial extracts, harvested macrophages were resuspended in an
isolation buffer (250 mM sucrose, 10 mM Tris-Base, 2 μg/ml DNase, pH 7.4)
with protease inhibitors. After three freeze-and-thaw cycles in liquid nitrogen and
incubation in 37 °C, respectively, unbroken cells and nuclei were removed by
centrifugation (750 ×g, 10 min). The supernatant was centrifuged for 20 min at
12000 ×g and pelletedmitochondriawere resuspended in an isolation buffer with
protease inhibitors. Protein content was determined by use of Sigma Procedure
TPRO-562 according to the manufacturer's protocol. Mitochondrial protein
extracts were loaded onto polyacrylamide gels, separated by electrophoresis and
transferred onto nitrocellulose membrane as previously described [17]. Western
blots were hybridized with appropriate antibodies under the following
conditions: UCP2, hUCP2-605 antibody (at 1/2000 dilution) and rabbit anti-
IgG (at 1/3000 dilution); porin, anti-porin antibody (Molecular Probes, at 1/4000
dilution) and mouse anti-IgG (Sigma-Aldrich, at 1/3000 dilution). Direct re-
cording of the chemiluminescence (ECL-kit) was performed using the
GeneGnome analyzer (Ozyme, St-Quentin Yvelines, France).
2.4. Quantitative ammonia and amino acid analysis
Macrophages were harvested and homogenized by sonication with a
Branson Digital Sonifier W-450D (Branson, Danbury, USA). Homogenized
samples were deproteinized by adding 1/10 volume of sulfosalicylic acid
solution (400 g/l) and centrifuged (10000 ×g, 5 min). Afterwards, 40 μl of the
supernatant was used for quantitative amino acid analysis by ion-exchange
chromatography and injected into a JEOL Aminotac JLC 500/V amino acid
analyzer (JEOL EUROPE SA, Croissy-sur-Seine, France) calibrated by
analyzing calibration standard of known concentration. Retention time was
used for amino acid identification and integration was used for quantification.
2.5. Measurements linked to mitochondrial activity
Oxygen consumption was measured in an oxygraph chamber (Hansatech
Instruments Ltd., Norfolk, England). Oligomycin (0.5 μg/ml final) was used to
evaluate the coupling of respiration in intact cells.
ATP was analyzed luminometrically (Lumat LB 9501, Berthold Technol-
ogies France SA, Thoiry, France) using a 10 s signal integration time. Lysis of
approximately 4 million cells was performed with 0.5 ml Passive Lysis Buffer,
5× (Promega corporation, Madison, USA). 10 μl of this lysate was diluted in
40 μl H2O and 50 μl of rLuc/Luc-Reagent (Promega Corporation, Madison,
USA). For quantification of ADP 200 μl of the cell lysate was added to 800 μl of
50 mM Tris/HCl, 0.5 mM EGTA, pH 8 and incubated for 30 min with 1 U/ml
myokinase at room temperature, then ATP concentration was determined as
above. ADP concentrations were obtained by subtraction of determined ATP
concentrations: [ADP]=[ATP] (after myokinase)− [ATP] (without myokinase).
Mitochondrial NADH/NAD+ ratios were estimated indirectly via quantita-
tive analysis of β-hydroxybutyrate and acetoacetate. Ratios of β-hydroxybuty-
rate to acetoacetate reflect directly the redox-state of the mitochondria and
thereby correspond directly with mitochondrial ratios of NADH/NAD+ [22–24].
Quantification of β-hydroxybutyrate and acetoacetate was performed spectro-
photometrically using a dual-wavelength spectrophotometer (SLM-Aminco
Fig. 2. Induction of UCP2 expression. After overnight incubation of BMDM,
isolated from UCP2-WT and UCP2-KO mice, in EBSS in the presence or
absence of 2 mM glutamine. Top: Mitochondrial fractions were prepared and
examined for UCP2 protein levels by Western blot analysis. As a control,
membranes were re-probed with anti-porin antibody. Bottom: The gel was
loaded with extracts from whole cells probed with actin and porin antibodies to
examine possible changes in mitochondrial content.
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reactions run at 30 °C in a final volume of 400 μl. After adding buffer and
coenzymes to the sample absorbance A1 was measured, the reaction was started
by addition of the appropriate enzyme. Measurement of absorbance A2 was
recorded after 20 min. The difference (A2−A1) of the reagent blank was
subtracted from the difference (A2−A1) of the sample. Concentrations were
determined by the use of standard of known concentration. Assay conditions for
determination of acetoacetate in 200 μl of cell culture media: 0.26 mM NADH
and 580 U/l hydroxybutyrate dehydrogenase in 80 mM Tris/HCl-buffer, pH 7.
Assay conditions for quantification ofβ-hydroxybutyrate in 200 μl of cell culture
media: 10 mM NAD+ and 580 U/l hydroxybutyrate dehydrogenase in 80 mM
Tris/HCl-buffer, pH 9.5.Fig. 3. Internal amino acids content of BMDM. BMDM were incubated
overnight (14–16 h) in EBSS in the presence or absence of 2 mM glutamine.
After preparation of total cell extracts of about 4 million cells, metabolite
quantitation was performed by ion-exchange chromatography (see Materials and
methods section). The concentrations of amino acids in these cellular extracts
(in μM) are plotted on a biparametric graph: each dot represents a single amino
acid, the X ordinate of the dot corresponds to its concentration in the Ucp2-WT
BMDM extract, and the Y ordinate to its concentration in the Ucp2-KO BMDM
extract. The error bars represent the s.e.m. (N=7 independent experiments).
White dots represent data obtained in the absence of glutamine and black dots in
its presence. The actual values (X and Y ordinate) of concentrations of amino
acid of special interest are shown on the graph. Indications italicized refer to
measures in the absence of glutamine, and those in plain text to values obtained
in the presence of glutamine.2.6. Quantification of glutamine oxidation with [U-14C]glutamine
Macrophages were cultured overnight (16 h) in PBS with or without 2 mM
glutamine and afterwards 0.175 μCi [U-14C]glutamine was added for 90 min.
The generated 14CO2 by approximately 4 million of macrophages was captured
in 70 μl 1MKOH and disintegration events per minute (dpm) were counted after
the addition of 2 ml liquid-scintillations-mix OptiPhase ‘HiSafe’3 in a Liquid
Scintillation Analyzer Tri-Carb 2100TR (Packard, GMI, Minnesota, USA).
3. Results
The presence of glutamine during overnight incubation in
EBSS allowed a robust expression of UCP2 whereas the ab-
sence of glutamine was associated with much lower expression
level (Fig. 2). As expected, no immunoreactive protein could be
detected in macrophages originating from Ucp2-KO mice.
Examination of relative immunoreactivity of porin and actin in
whole cell extracts indicated no difference between BMDM
originating from Ucp2-KO or -WT mice, without noticeable
effect of glutamine exposure.
The purpose of all the following experiments was to compare
Ucp2-KO to Ucp2-WT BMDM in the same conditions. There-
fore, experiments were made with paired overnight incubations
of Ucp2-KO and Ucp2-WT BMDM in the presence or absence
of glutamine.Fig. 4. Effect of inhibitors. Measurement of internal content in the amino acids
alanine (taken as an internal control), aspartate, glutamate, and glutamine, in
BMDM incubated overnight in EBSS plus 2 mM glutamine. WT: Ucp2-WT
BMDM, KO: Ucp2-KO BMDM, values are shown ±s.e.m. A: In the absence of
inhibitors, the values are the same as those shown in Fig. 3, ⁎Pb0.05, ⁎⁎Pb0.01
(t test). B: In the presence of 5mMofAOA. C: In the presence of 20mMofDON.
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Ucp2-WT and Ucp2-KO BMDM is shown (Fig. 3). When
there is no difference between the two types of BMDM dots are
aligned according to the first diagonal. This is observed when
Ucp2-WT and Ucp2-KO BMDM are compared in the EBSS
medium (Fig. 3, white dots). In contrast, when glutamine was
present Ucp2-KO BMDM accumulated more glutamine, gluta-
mate and aspartic acid (Fig. 3A, black dots). The logarithmic
scale used minimizes the actual differences which can be seen in
Fig. 4. Addition of 20 mM of the glutaminase inhibitor DON
or of 5 mM of the transaminase inhibitor AOA abolished the
differences in intracellular glutamine, glutamate and aspartate
concentrations between Ucp2-WT and Ucp2-KO BMDM
(Fig. 4).
The cellular respiration of BMDM was recorded after incu-
bation of BMDM in EBSS or EBSS+Gln as for the previous
experiment. After 16 h in EBSS both types of BMDM showed a
similar respiratory rate (Fig. 5A top). In contrast, after 16 h inFig. 5. Oxidativemetabolism. A) Respiration was determined in BMDM that had
been incubated overnight in EBSS±2 mM glutamine. The number of inde-
pendent experiment (N) is indicated, mean values are shown ±s.e.m. ⁎⁎Pb0.01,
⁎⁎⁎Pb0.001 (t test). B) The ammonium ion concentration was determined in the
same cellular extracts as in Fig. 3. The value obtained with BMDM incubated in
PBS+Gln is also shown. C) Aspartate concentration in cellular extracts. The
values in EBSS+Gln are shown again for the comparison with the values
obtained when BMDM were incubated in PBS+Gln.
Fig. 6. Kinetic. A) The mean±s.e.m. values of the ratio between concentration
of glutamine (diamonds), glutamate (triangles), aspartate (circles), ammonium
(squares) and alanine (thick black line and small black circles), are shown before
glutamine addition: time zero (N=4), 30 min (N=3), 1 (N=2), 3 (N=4),
5 (N=2), 8 (N=3) and 16 (N=4) hours after glutamine addition. B) Actual
values of concentration of metabolites in cellular extracts during the 0–3 h
period of the experiments shown in A. For clarity the glutamine concentration is
not shown. Symbols as above with empty symbols and dotted line for Ucp2-WT
BMDM, black symbols and solid line for Ucp2-KO BMDM.EBSS+Gln Ucp2-WT BMDM showed a doubled respiratory
rate when compared to Ucp2-KO BMDM (Fig. 5A middle).
This appeared to be due to an increase in respiration induced by
glutamine in WT rather than to a decrease in the KO. The same
difference was observed in experiments where BMDM were
incubated in a medium in which glutamine was the only avail-
able substrate (Fig. 5A bottom). The respiratory rate of BMDM
in the presence of oligomycin, an inhibitor of the mitochondrial
Fo-F1 ATP synthase, is explained by ion cycling across the
mitochondrial inner membrane. Activation of uncoupling func-
tion of a UCP increases the respiratory rate in the presence of
oligomycin (see Fig. 6B of [25] for a recent example) and
decreases the ratio between the spontaneous respiratory rate and
the rate observed after addition of oligomycin. After incubation
in EBSS+Glutamine for 16 h this ratio was 5.7±1.4 with
Ucp2-WT BMDM and 4.4±0.67 with the Ucp2-KO BMDM
(N=5 P=0.23). Therefore these ratios provided evidence
against a relatively uncoupled state of mitochondria in Ucp2-
WT BMDM when compared to Ucp2-KO BMDM.
Ammonium ion is a final metabolite of glutamine oxidation
(Fig. 1). In the absence of glutamine similar concentration of
Fig. 8. Respiration of mitochondria in permeabilized BMDM. After the recording
of cellular respiration of intact BMDM “Intact cells”, the cells were permeabilized
with digitonin (150 μM) in the presence of rotenone (1.25 μM) to allow recording
of mitochondrial respiration in the presence of succinate (19 mM). This was made
in the presence of ADP (1.5 mM): state 3 and then oligomycin (0.5 μg/ml) was
added to record the state 4 rate. Values are shown as mean±s.e.m. of three
independent experiments.
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was present ammonium content was doubled in Ucp2-WT
BMDM compared toUcp2-KOBMDM (Fig. 5B) independently
from presence of glucose. While the relative difference in as-
partate concentration between Ucp2-WT and Ucp2-KO BMDM
remained the same, the absolute cellular content in aspartate was
greatly enhanced in the absence of glucose (Fig. 5C).
Kinetic experiments were performed to examine the order of
accumulation of the early metabolites of glutamine catabolism
in Ucp2-KO BMDM (Fig. 6). To evidence relative accumula-
tion in Ucp2-KO BMDM the ratio between metabolite con-
centration in the two types of BMDM was calculated (Fig. 6A).
As expected, the ratio remained around one for alanine. After
3 h accumulation of aspartate in Ucp2-KO BMDM (ratio above
one) was detected and followed by glutamate and finally by
glutamine accumulation. Consistent with above (Fig. 5B) the
ratio decreased for the ammonium ion. This representation
indicates that during the first hours of incubation the two types
of BMDM did not behave differently but provides no
information about the appearance of glutamine metabolites.
Representation of amino acid concentration during this early
phase of glutamine exposure is shown in Fig. 6B. The intra-
cellular content in aspartate and glutamate increased quickly in
the same manner for both types of BMDM. Identical kinetics for
the cellular content in ammonium ion and alanine was also
observed (Fig. 6B). Therefore, these experiments showed that
the kinetic accumulation of glutamine metabolites could be
divided in two periods: i) an early phase from zero to less than
3 h, with no difference between both types of BMDM. ii) A later
phase 3–16 h during which the Ucp2-WT produces more
ammonium and the Ucp2-KO accumulates aspartate. These
experiments provided information about the relative activity of
glutaminase and transaminase (steps 1 and 2b in Fig. 1) within
living BMDM but provided no indication about the glutamate
dehydrogenase (step 2a in Fig. 1). The dosage of the activity of
this enzyme was performed in two independent preparations of
Ucp2-WT or Ucp2-KO BMDM. The values in nmol/min/mg
protein after overnight exposure in EBSS were 3.4, 1.3 in WT
and 4.2, 5.6 in KO. Similar values (5.1, 1.4 inWT and 5.8, 3.7 in
KO) were obtained after overnight exposure in EBSS+Gln.Fig. 7. Oxidation of radio labeled glutamine. Mean±s.e.m. of the carbon dioxide
release from radio labeled glutamine obtained with BMDM that had been
starved for 16 h in PBS “PBS” or BMDM that had been exposed for 16 h to
PBS+Gln “PBS+Gln”.Therefore, no indication for a deficiency in the activity of
enzymes of glutamine metabolism could be observed when
Ucp2-KO BMDM was compared to Ucp2-WT BMDM.
The release of carbon dioxide from radio labeled glutamine
was estimated (Fig. 7). When BMDM had not been exposed to
glutamine the rate of oxidation is similar in the two types of
cells whereas after exposure to glutamine the relative rates of
Ucp2-KO and Ucp2-WT BMDM seemed to differ to an extent
similar to that observed with cellular respiration or ammonium
release (Fig. 5).
Permeabilization of BMDM by digitonin allowed to study
BMDM mitochondria oxidizing succinate. In these experiments
identical activity of mitochondria in Ucp2-KO BMDM and
Ucp2-WT BMDM in phosphorylating state 3 and state 4 con-
trasted with the difference observed in intact cells (Fig. 8).
Therefore, activities of complexes II to IVas well as the coupled
state of mitochondria appeared identical in both types of BMDM.
ATP/ADP ratio was estimated in BMDM after overnight
incubation in EBSS in the presence of glutamine. UncouplingFig. 9. ATP/ADP and BOB/AcAc concentration ratios. ATP/ADP ratio and beta-
hydroxybutyrate (BOB)/acetoacetate (AcAc) ratio were determined in BMDM that
had been incubated overnight in EBSS±2 mM glutamine. The number of indepen-
dent experiments (N) is indicated, mean values are shown ±s.e.m. ⁎⁎Pb0.01 (t test).
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was not the case (Fig. 9A). β-hydroxybutyrate to acetoacetate
ratio was used as an index of intra-mitochondrial NADH/NAD
ratio. It indicated a more reduced state of mitochondria inUcp2-
WT BMDM (Fig. 9B).
4. Discussion
Two characteristics of this study should be recalled: i) The
BMDM used were in a non-activated state. Therefore, com-
parison with situations where activation of macrophages has
taken place should be made with caution. ii) The important fuel
glucose was kept to a physiological concentration of 5 mM. The
relative differences between Ucp2-KO and Ucp2-WT BMDM
were also found when BMDM had been incubated overnight
in the presence of glutamine and in the absence of glucose i.e.
PBS+glutamine (Fig. 5).
Entry of glutamine in the oxidative pathway involves gluta-
minase that releases ammonium and produces glutamate (step 1
in Fig. 1). Entry of glutamate into the Krebs cycle can occur
through oxidative deamination by glutamate dehydrogenase
(2a in Fig. 1) yielding a second ammonium ion or transamination
(2b in Fig. 1), for which an obvious candidate is oxaloacetate
yielding aspartate. In this scheme there are two glutamine end
products that need to be eliminated somehow. One is ammonium,
the other is aspartate. Ucp2-WT and Ucp2-KO BMDM clearly
differed by their relative accumulation of these two metabolites
(Figs. 3–6). At this point, it should be precised that measurements
of intracellular content in amino acids or ammonium do not
provide absolute values of the fluxes of metabolites but provided
an estimation of the relative difference in the production rate of
these molecules within the two types of BMDM.
After prolonged exposure to glutamine the respiratory rate of
Ucp2-WT was higher than that of Ucp2-KO cells. Experiments
with permeabilized BMDM (Fig. 8) showed that the functional
state of mitochondrial complexes II–V is not different in both
types of BMDM. This rules out the possibility that the decreased
respiratory rate of Ucp2-KO BMDM would be due to a general
decline of mitochondria in Ucp2-KO BMDM exposed to
glutamine for several hours. Use of oligomycin, and estimation
of ATP/ADP ratio in BMDM revealed unchanged coupling
parameters. This was also the case when BMDM mitochondria
were examined more directly (Fig. 8). This argues against
uncoupling activity of UCP2 to be the explanation for the
observed increase in respiratory rate and glutamine catabolism in
Ucp2-WT BMDM. Actually, the increased reduced state of
coenzymes observed inUcp2-WT BMDM provides the alternate
explanation that a more intense substrate supply to the mito-
chondrial respiratory chain would be the reason for the increase
in respiratory rate in Ucp2-WT BMDM. In the absence of
uncoupling activity (proton transport), another transport activity
across the mitochondrial inner membrane is expected to explain
the effect of UCP2 in BMDM. Obviously, UCP2 is not required
for entry of glutamine into mitochondria since intra-mitochond-
rially produced metabolites accumulate (Figs. 1 and 3–6).
During the first hours of glutamine exposure apparition of
metabolites was identical in both types of BMDM (Fig. 6). It wasalso observed that in PBS+Gln accumulation of aspartate was
approximately four times more intense than in EBSS+Gln with
identical relative difference between KO and WT (Fig. 5C).
Therefore, it appears unlikely that a constitutive limitation in
activity of either glutaminase or transaminase could be the
explanation for increased accumulation of aspartate inUcp2-KO
BMDM.
The defect in Ucp2-KO BMDM appears as a delayed
phenomenon resulting in failure to maintain or to induce an
oxidative metabolism as intense as the WT does (Figs. 5A
and 7). This delayed effect of UCP2 absence has to be con-
sidered in parallel with the fact that glutamine exposure of the
cells stimulates translation of UCP2 mRNA and thus increases
mitochondrial UCP2 content [19]. This stimulation takes ap-
proximately 2 h to reach its maximal intensity [19]. Establish-
ment of differences between Ucp2-KO and Ucp2-WT BMDM
(Fig. 6) appears therefore to correlate with the time needed to
reach the maximal expression of UCP2.
In a recent study we propose that UCP2 would control the
balance between oxidative metabolism (fatty acid oxidation) and
glucose metabolism in mouse embryonic fibroblasts [26]. The
availability of pyruvate to mitochondria was proposed as the
target for UCP2 or UCP3 action [25,26]. In these studies
emphasis was put on the relative importance of the strictly
oxidative catabolism of fatty acids [26] or of galactose [25] with
regard to the use of glucose. The mere observation of the relative
production of metabolites in BMDM in the present study
suggests that when glutamine is offered UCP2 promotes a
complete oxidation with enhanced release of ammonium and
conversely UCP2 absence results in an incomplete oxidation
characterized by increased aspartate production, and limited
supply of reduced coenzymes to the mitochondrial respiratory
chain. It is likely that this role of UCP2 as a regulator of oxidative
metabolism is not restricted to macrophages as glutamine expo-
sure increases translation of UCP2mRNA in all the different cell
types examined so far [19].
Associated with data from other groups [27–29], our work
reinforces the hypothesis that the physiological role of UCP2 is
the control of how/which mitochondrial substrates are used
(Fig. 1 “UCP2 B”). This effect of UCP2 occurred in the absence
of stimulation of its uncoupling activity. Therefore, although the
exact mechanism (transport activity of UCP2) remains to be
determined, this report represents a landmark in understanding
the importance of UCP2 for cellular metabolism.
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